Reboot Rx
@Reboot_Rx
Tech nonprofit fast-tracking the development of affordable cancer treatments using repurposed generic drugs and AI technology. #TheSolutionMayAlreadyExist
Last week we had the privilege of participating in @FfwdOrg #DemoDay2020. If you were unable to join, you can watch our pitch here: youtu.be/HUy0DLBh44w! #FFWD20 #philanthropy #nonprofit #startup #innovation #cancer #research #AI #technology #drugrepurposing #patientimpact
Repurposing existing drugs offers a faster, more affordable path to cancer treatments, but no sector can do it alone. We’re grateful to work with partners who share our commitment to helping patients access effective, low-cost therapies. #TheSolutionMayAlreadyExist

Another fantastic #PrevConf25 conference with @CR_UK, @AmericanCancer, & @theNCI! Energizing discussions on repurposing generics for #cancerprevention and early interception. Highlight: connecting with Sir John Burns about the @CaPP3 trial results. #TheSolutionMayAlreadyExist
It's International #MensHealthWeek—a crucial time to talk about cancer awareness. 1 in 5 men will face a cancer diagnosis, and early detection saves lives. Encourage the men in your life to talk to their doctor and stay up to date with testing. #TheSolutionMayAlreadyExist

This #NationalCancerSurvivorsDay, we honor all living with & beyond cancer. We’re inspired by our advisor @dougulman, whose lived cancer experience has driven lasting change with @ulmanfoundation, @livestrong, @pelotonia, and ORLI. #TheSolutionMayAlreadyExist #NCSD2025

At @DukeMargolis, Devon Crittenden presented Reboot Rx’s proposed Labeling-Only Repurposing Pathway. This common-sense extension of the 505(b)(2) pathway would streamline FDA approvals for nonprofits pursuing new uses for generics and expand access. #TheSolutionMayAlreadyExist


Join us on May 29 for a @DukeMargolis workshop on how regulatory and policy solutions can help overcome key challenges in generic drug repurposing. Our team will be presenting alongside other experts. healthpolicy.duke.edu/events/generic… #TheSolutionMayAlreadyExist

May is #NationalCancerResearchMonth. ~15% of generics have shown promise for treating new cancer indications, but we need clinical trials to prove what works. Check out the funding opportunity for AI-driven trials from @CuresWReach & @ChanZuckerberg! #TheSolutionMayAlreadyExist

At #iDR25, our CEO @LauraBKleiman joined leaders from @Anticancerfund, @CuresWReach, @KingsCollegeLon, @AmsterdamUMC, & @LUMC_leiden to discuss new efforts to expand patient access to repurposed generic drugs. #TheSolutionMayAlreadyExist #DrugRepurposing



Excited to connect with colleagues at #iDR25 next week in Amsterdam! If you’re working on generic #drugrepurposing and think a regulatory approval pathway could help, please reach out. Agenda: remedi4all.org/2025-internati… @Reboot_Rx @REMEDi4ALL @RareBeacon #TheSolutionMayAlreadyExist
At #TxBiomedGHS, @LauraBKleiman joined John Ainslie, Kristi Cooper, Matt Crommett, and moderator Aaron Asel to highlight how philanthropic support can bring affordable, evidence-based cancer care to patients faster. Bold funding makes bold impact! #TheSolutionMayAlreadyExist

#MeetTheTeam - Meet Kathleen Berryman, our new Manager of Business Operations at Reboot Rx! With 15+ years of nonprofit & for-profit business ops experience, we're excited to have her on the team! Learn more: rebootrx.org/berryman. #PatientImpact #TheSolutionMayAlreadyExist

Join our CEO @LauraBKleiman at #ASPET2025 for Friday’s keynote on how AI + repurposed generic drugs are unlocking access to cancer care! 📅 April 4 | ⏰ 9–10 AM PDT #PatientImpact #DrugRepurposing #CancerResearch #Innovation #SocialImpact #RebootRx #TheSolutionMayAlreadyExist

Our CEO, @LauraBKleiman, spoke on the "Value & Product-Market Fit" panel at HealthTech Build. She shared about achieving real-world adoption of affordable cancer treatments by overcoming barriers and aligning incentives. #Innovation #WomenInScience #TheSolutionMayAlreadyExist


Glad to join the Data-Driven #DrugRepurposing panel at the @MITSloan Healthcare Conference to discuss how repurposing will reshape the clinical landscape over the next 10 years. And great to catch up with former @Reboot_Rx team member @GloriaJWu! #TheSolutionMayAlreadyExist
We are proud supporters of @Reboot_Rx, which uses AI technology to fast-track the development of affordable cancer treatments through repurposed generic drugs. Founder and CEO @LauraBKleiman was featured in the Boston News: watch the segment to learn more about how Laura and her…
Thank you to @boston25 & @ksullivannews for featuring @Reboot_Rx & @LauraBKleiman! The segment highlights our work advancing affordable, evidence-based #cancer treatments and how it could be a game changer. Watch: boston25news.com/news/local/its… @DRKFoundation #TheSolutionMayAlreadyExist
Today, on #WorldCancerDay, we honor patients, caregivers, and those working to cure cancer. At Reboot Rx, we’re advancing affordable, evidence-based treatments to improve patient outcomes. Together, we can create a future where everyone has access to the care they need.

🚀 We are hiring a Manager of Business Operations! This role will support our internal organizational processes and team as we develop affordable cancer treatments. linkedin.com/jobs/view/4126… #cancer #healthcare #patientimpact #operations #nonprofit #startups #hiring #jobs
💡 Check out our policy memo published by @scientistsorg! We propose a dedicated regulatory pathway for non-manufacturers to seek FDA approval of new indications for repurposed generic drugs. Thank you to @Arnold_Ventures for funding. 👉 fas.org/publication/cl… #DayOne2025
🚀 We’re Hiring! Reboot Rx is seeking a Head/VP of Commercialization and Patient Impact to lead the charge in launching accessible and affordable #cancer treatments that improve the standard of care for patients. Help us spread the word. linkedin.com/jobs/view/4118…